Suppr超能文献

基于脐血移植的急性白血病患者生存预测的综合评分系统。

An Integrative Scoring System for Survival Prediction Following Umbilical Cord Blood Transplantation in Acute Leukemia.

机构信息

Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-HaShomer, Ramat-Gan, Israel.

Dr. Pinchas Bornstein Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-HaShomer, Ramat-Gan, Israel.

出版信息

Clin Cancer Res. 2017 Nov 1;23(21):6478-6486. doi: 10.1158/1078-0432.CCR-17-0489. Epub 2017 Jul 28.

Abstract

Survival of acute leukemia (AL) patients following umbilical cord blood transplantation (UCBT) is dependent on an array of individual features. Integrative models for risk assessment are lacking. We sought to develop a scoring system for prediction of overall survival (OS) and leukemia-free survival (LFS) at 2 years following UCBT in AL patients. The study cohort included 3,140 pediatric and adult AL UCBT patients from the European Society of Blood and Marrow Transplantation and Eurocord registries. Patients received single or double cord blood units. The dataset was geographically split into a derivation ( = 2,362, 65%) and validation set ( = 778, 35%). Top predictors of OS were identified using the Random Survival Forest algorithm and introduced into a Cox regression model, which served for the construction of the UCBT risk score. The score includes nine variables: disease status, diagnosis, cell dose, age, center experience, cytomegalovirus serostatus, degree of HLA mismatch, previous autograft, and anti-thymocyte globulin administration. Over the validation set an increasing score was associated with decreasing probabilities for 2 years OS and LFS, ranging from 70.21% [68.89-70.71, 95% confidence interval (CI)] and 64.76% (64.33-65.86, 95% CI) to 14.78% (10.91-17.41) and 18.11% (14.40-22.30), respectively. It stratified patients into six distinct risk groups. The score's discrimination (AUC) over multiple imputations of the validation set was 68.76 (68.19-69.04, range) and 65.78 (65.20-66.28) for 2 years OS and LFS, respectively. The UCBT score is a simple tool for risk stratification of AL patients undergoing UCBT. Widespread application of the score will require further independent validation. .

摘要

急性白血病(AL)患者在接受脐带血移植(UCBT)后的生存取决于一系列个体特征。目前缺乏综合的风险评估模型。我们旨在为 AL 患者在 UCBT 后 2 年的总生存(OS)和无白血病生存(LFS)建立预测评分系统。该研究队列包括来自欧洲血液和骨髓移植协会和欧洲 cord 注册中心的 3140 名儿科和成人 AL UCBT 患者。患者接受了单份或双份脐带血单位。数据集在地理上分为推导集(=2362,65%)和验证集(=778,35%)。使用随机生存森林算法确定 OS 的主要预测因素,并将其引入 Cox 回归模型,用于构建 UCBT 风险评分。该评分包括 9 个变量:疾病状态、诊断、细胞剂量、年龄、中心经验、巨细胞病毒血清状态、HLA 错配程度、既往自体移植和抗胸腺细胞球蛋白的使用。在验证集中,评分越高,2 年 OS 和 LFS 的概率越低,从 70.21%(68.89-70.71,95%置信区间[CI])和 64.76%(64.33-65.86,95%CI)到 14.78%(10.91-17.41)和 18.11%(14.40-22.30)。它将患者分为六个不同的风险组。该评分在验证集的多个插补中的区分度(AUC)为 68.76(68.19-69.04,范围)和 65.78(65.20-66.28),分别用于 2 年 OS 和 LFS。UCBT 评分是一种用于接受 UCBT 的 AL 患者风险分层的简单工具。该评分的广泛应用需要进一步的独立验证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验